Late embolization of Amplatzer patent ductus arteriosus occlusion device with thoracic aorta embedment

David Michael McMullan1, Achintya Moulick, Richard A Jonas

  • 1Cardiovascular Surgery, Children's National Medical Center, Washington, District of Columbia 20010, USA. dmcmulla@cnmc.org

Insights

A child experienced a widely patent ductus arteriosus after Amplatzer device closure due to device migration. Surgical removal was necessary as the device became embedded in the descending thoracic aorta.

Area of Science:

  • Cardiovascular medicine
  • Pediatric cardiology
  • Interventional cardiology

Background:

  • Percutaneous closure of patent ductus arteriosus (PDA) using devices like the Amplatzer is a common pediatric procedure.
  • While generally safe and effective, potential complications such as device migration can occur.

Observation:

  • An 11.5-month-old child presented with a widely patent ductus arteriosus eight months post-Amplatzer device closure.
  • Diagnostic angiography revealed that the occlusion device had migrated from its intended position within the ductus to the descending thoracic aorta.

Findings:

  • The migrated Amplatzer device was firmly embedded within the descending thoracic aorta.
  • Percutaneous removal of the embedded device was not feasible.

Implications:

  • Device migration is a rare but serious complication of percutaneous PDA closure, necessitating careful monitoring.
  • Surgical intervention may be required for the removal of migrated cardiac occlusion devices.
  • This case highlights the importance of considering device integrity and anatomical variations in pediatric cardiovascular interventions.

Related Concept Videos